S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Fund/Perceptive Advisors/Q2 2022

Perceptive Advisors

Periodo: Q2 2022 Β· Depositato: 2022-08-15
Vedi su SEC EDGAR β†—
AUM
$3.19B
Valore totale del portafoglio
Posizioni
111
Titoli dichiarati
Prima Posizione
14.3% $455.9M
Var. Trimestrali
+8 / -8
nuovi Β· usciti
⚠️Informativa sui Depositi 13F

I dati AUM mostrati sono calcolati sommando il valore di mercato dichiarato di tutte le posizioni nei depositi SEC 13F-HR β€” non rappresentano il patrimonio effettivo gestito dal fondo.

  • Escluse liquiditΓ , obbligazioni, private equity, posizioni corte e azioni estere non soggette all'obbligo di dichiarazione.
  • Per le opzioni PUT e CALL, il Valore dichiarato Γ¨ il valore nozionale delle azioni sottostanti β€” non il premio pagato. CiΓ² sovrastima significativamente il capitale effettivamente a rischio.
  • Il patrimonio reale del fondo Γ¨ tipicamente superiore e include strategie, strumenti e posizioni che non compaiono mai in un 13F.
  • I depositi 13F riguardano i gestori istituzionali con β‰₯$100M in titoli 13F. Le posizioni riflettono le partecipazioni a fine trimestre, divulgate entro 45 giorni dalla fine del periodo.

Dati provenienti da SEC EDGAR. Questo tracker Γ¨ a scopo puramente informativo e non costituisce consulenza finanziaria.

Partecipazioni in Portafoglio

Prime 30 posizioni

⚠️ Performance % calcolata dalla data di deposito ( 2022-08-15) si riferisce al titolo sottostante β€” non al P&L del derivato.
TickerEmittenteNozionalePortafoglio %Al DepositoOra (Fine Giornata)Dal DepositoAllocazione
TRAVERE THERAPEUTICS INC$455.9M14.28%β€”β€”
14.3%
FOLDAMICUS THERAPEUTICS INC$288.9M9.05%β€”β€”
9.1%
MRTXMIRATI THERAPEUTICS INC$192.4M6.03%β€”β€”
6.0%
CERECEREVEL THERAPEUTICS HLDNG I$134.5M4.21%β€”β€”
4.2%
IOVAIOVANCE BIOTHERAPEUTICS INC$130.6M4.09%$11.04$4.31-61.0%
4.1%
LIANYLIANBIO$122.2M3.83%$0.00$0.12
3.8%
CRNXCRINETICS PHARMACEUTICALS IN$99.2M3.11%$18.65$42.23+126.4%
3.1%
GBTGLOBAL BLOOD THERAPEUTICS IN$96.3M3.02%β€”β€”
3.0%
SWTXSPRINGWORKS THERAPEUTICS INC$95.2M2.98%β€”β€”
3.0%
AMLXAMYLYX PHARMACEUTICALS INC$68.2M2.14%$19.26$18.27-5.1%
2.1%
XENEXENON PHARMACEUTICALS INC$64.6M2.02%$30.42$60.96+100.4%
2.0%
MGTXMEIRAGTX HLDGS PLC$52.7M1.65%$7.57$13.92+83.9%
1.6%
LYRAXXXXLYRA THERAPEUTICS INC$51.7M1.62%β€”β€”
1.6%
BLUBELLUS HEALTH INC NEW$51.1M1.60%β€”β€”
1.6%
RXDXPROMETHEUS BIOSCIENCES INC$47.5M1.49%β€”β€”
1.5%
ALBOALBIREO PHARMA INC$46.9M1.47%β€”β€”
1.5%
CINCCINCOR PHARMA INC$43.7M1.37%β€”β€”
1.4%
VBIVXXXXVBI VACCINES INC CDA$42.3M1.33%β€”β€”
1.3%
SGENSEAGEN INC$39.6M1.24%β€”β€”
1.2%
VERUXXXXVERU INC$39.5M1.24%β€”β€”
1.2%
ALDXALDEYRA THERAPEUTICS INC$39.5M1.24%$3.99$2.27-43.1%
1.2%
NBIXNEUROCRINE BIOSCIENCES INC$38.8M1.21%$97.48$174.26+78.8%
1.2%
RAPTRAPT THERAPEUTICS INC$34.9M1.09%β€”β€”
1.1%
RLAYRELAY THERAPEUTICS INC$32.5M1.02%$16.75$18.65+11.3%
1.0%
LLYLILLY ELI & CO$32.4M1.02%$313.65$1213.91+287.0%
1.0%
COHERUS BIOSCIENCES INC$29.5M0.92%β€”β€”
0.9%
COGTCOGENT BIOSCIENCES INC$27.9M0.87%$9.02$38.69+328.9%
0.9%
CHRSCOHERUS BIOSCIENCES INC$26.4M0.83%$7.24$1.45-80.0%
0.8%
MDGLMADRIGAL PHARMACEUTICALS INC$26.3M0.82%$71.58$528.10+637.8%
0.8%
ALNYALNYLAM PHARMACEUTICALS INC$25.2M0.79%$145.85$312.78+114.5%
0.8%

AttivitΓ  Trimestre su Trimestre

Q2 2022 vs. Q1 2022

Nuove Posizioni (8)

TickerEmittenteNozionaleDal Deposito
SGENSEAGEN INC$39.6M
LLYLILLY ELI & CO$32.4M+287.0%
ACLXARCELLX INC$20.6M
HRMYHARMONY BIOSCIENCES HLDGS IN$20.1M
BMRNBIOMARIN PHARMACEUTICAL INC$14.9M
HLVXHILLEVAX INC$8.4M
XBIPUTSPDR SER TR$7.4M
YMABY-MABS THERAPEUTICS INC$3.2M

Posizioni Chiuse (8)

TickerEmittenteNozionale
AGRXXXXXAGILE THERAPEUTICS INC$178.4M
HZNPHORIZON THERAPEUTICS PLC$142.9M
COLLEGIUM PHARMACEUTICAL INC$89.5M
NVRONEVRO CORP$34.5M
PENPENUMBRA INC$31.9M
ZNTLZENTALIS PHARMACEUTICALS INC$23.1M
LEGNLEGEND BIOTECH CORP$22.4M
AXNXAXONICS INC$21.4M

Aumentate (8)

TickerEmittenteNozionaleVar. AzioniDal Deposito
RVNCREVANCE THERAPEUTICS INC$5.2M+316.3%
LYRAXXXXLYRA THERAPEUTICS INC$38.7M+183.8%
AMLXAMYLYX PHARMACEUTICALS INC$49.3M+140.2%-5.1%
WGSSEMA4 HOLDINGS CORP$-1.4M+100.0%
AORTARTIVION INC$4.4M+51.0%
ATHAATHIRA PHARMA INC$-31.6M+40.0%
VRCAVERRICA PHARMACEUTICALS INC$-19.6M+39.6%
MDGLMADRIGAL PHARMACEUTICALS INC$-1.0M+32.1%+637.8%

Ridotte (8)

TickerEmittenteNozionaleVar. Azioni
SRZNSURROZEN INC$-0.2M-92.3%
PRVBPROVENTION BIO INC$-5.3M-86.0%
APLSAPELLIS PHARMACEUTICALS INC$-60.8M-78.3%
CCXICHEMOCENTRYX INC$-30.6M-73.3%
TVTXTRAVERE THERAPEUTICS INC$-33.8M-69.1%
CCCCC4 THERAPEUTICS INC$-44.8M-63.2%
ISEEIVERIC BIO INC$-67.9M-60.0%
BBIOBRIDGEBIO PHARMA INC$-23.6M-55.8%
← Torna agli Hedge Fund